Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Study

Foley, PeterPeterFoleyTSEN-FANG TSAIRodins, KarlKarlRodinsHamadah, Issam RibhiIssam RibhiHamadahAmmoury, AlfredAlfredAmmouryDayem, Hussein AbdelHussein AbdelDayemAbdallah, MahmoudMahmoudAbdallahet al.,et al.2022-09-202022-09-202022-022193-8210https://scholars.lib.ntu.edu.tw/handle/123456789/621249Secukinumab has demonstrated sustained long-term efficacy with a favourable safety profile in various manifestations of psoriatic disease. We investigated effectiveness and safety of secukinumab, other biologics and conventional systemic therapies in patients with chronic plaque psoriasis in a real-world setting.enBiologics; Psoriasis; Real-world; Safety; Secukinumab[SDGs]SDG3Effectiveness and Safety of Secukinumab for Psoriasis in a Real-World Clinical Setting in the Asia-Pacific and Middle East Regions: Results from the REALIA Studyjournal article10.1007/s13555-021-00675-w350381282-s2.0-85123084066WOS:000743403200002https://api.elsevier.com/content/abstract/scopus_id/85123084066